450 related articles for article (PubMed ID: 3668252)
1. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
Rotrosen D; Malech HL; Gallin JI
J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
[TBL] [Abstract][Full Text] [Related]
2. Formyl peptide chemotaxis receptors on the rat neutrophil: experimental evidence for negative cooperativity.
Marasco WA; Feltner DE; Ward PA
J Cell Biochem; 1985; 27(4):359-75. PubMed ID: 2987275
[TBL] [Abstract][Full Text] [Related]
3. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
Mackin WM; Huang CK; Becker EL
J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
Borish L; O'Reilly D; Klempner MS; Rocklin RE
J Immunol; 1986 Sep; 137(6):1897-903. PubMed ID: 3018081
[TBL] [Abstract][Full Text] [Related]
5. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
Harvath L; Aksamit RR
J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of a bifunctional ligand of the formyl peptide receptor1 fused to the myc epitope.
Charest-Morin X; Roy C; Fernandes MJ; Marceau F
Int Immunopharmacol; 2015 Mar; 25(1):229-34. PubMed ID: 25681283
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) regulates f Met-Leu-Phe receptors on human neutrophils.
Atkinson YH; Lopez AF; Marasco WA; Lucas CM; Wong GG; Burns GF; Vadas MA
Immunology; 1988 Jul; 64(3):519-25. PubMed ID: 2842255
[TBL] [Abstract][Full Text] [Related]
8. Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.
Fletcher MP; Seligmann BE; Gallin JI
J Immunol; 1982 Feb; 128(2):941-8. PubMed ID: 6274963
[TBL] [Abstract][Full Text] [Related]
9. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
[TBL] [Abstract][Full Text] [Related]
10. Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors.
Weisbart RH; Golde DW; Gasson JC
J Immunol; 1986 Dec; 137(11):3584-7. PubMed ID: 3491142
[TBL] [Abstract][Full Text] [Related]
11. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
Donabedian H; Gallin JI
J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
[TBL] [Abstract][Full Text] [Related]
12. Ligand-induced adhesion to activated endothelium and to vascular cell adhesion molecule-1 in lymphocytes transfected with the N-formyl peptide receptor.
Honda S; Campbell JJ; Andrew DP; Engelhardt B; Butcher BA; Warnock RA; Ye RD; Butcher EC
J Immunol; 1994 Apr; 152(8):4026-35. PubMed ID: 7511663
[TBL] [Abstract][Full Text] [Related]
13. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.
Marasco WA; Becker EL
J Immunol; 1982 Feb; 128(2):963-8. PubMed ID: 7054297
[TBL] [Abstract][Full Text] [Related]
14. Effects of tunicamycin on the expression and function of formyl peptide chemotactic receptors of differentiated HL-60 cells.
Heiman DF; Gardner JP; Apfeldorf WJ; Malech HL
J Immunol; 1986 Jun; 136(12):4623-30. PubMed ID: 3011898
[TBL] [Abstract][Full Text] [Related]
15. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
Dentino AR; Raj PA; De Nardin E
Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
[TBL] [Abstract][Full Text] [Related]
16. Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
Andersson T; Dahlgren C; Pozzan T; Stendahl O; Lew PD
Mol Pharmacol; 1986 Nov; 30(5):437-43. PubMed ID: 2430168
[TBL] [Abstract][Full Text] [Related]
17. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
[TBL] [Abstract][Full Text] [Related]
18. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C
Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
Harvath L; McCall CE; Bass DA; McPhail LC
J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
[TBL] [Abstract][Full Text] [Related]
20. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]